United Therapeutics(UTHR.US) Director Sells US$1.98 Million in Common Stock

$United Therapeutics(UTHR.US)$ Director ROTHBLATT MARTINE A sold 7,200 shares of common stock on May 20, 21, 2024 at an average price of $274.9683 for a total value of $1.98 million.Source: Announceme

Futu News05:15

Expert Ratings For United Therapeutics

During the last three months, 7 analysts shared their evaluations of United Therapeutics (NASDAQ:UTHR), revealing diverse outlooks from bullish to bearish.The following table encapsulates their recent

BenzingaMay 22 01:00

United Therapeutics Is Maintained at Overweight by JP Morgan

United Therapeutics Is Maintained at Overweight by JP Morgan

Dow JonesMay 22 00:23

Komo: Maintaining the United Therapeutics (UTHR.US) rating, adjusted from an increase holdings to an increase rating, and the target price was adjusted from $280.00 to $300.00.

Komo: Maintaining the United Therapeutics (UTHR.US) rating, adjusted from an increase holdings to an increase rating, and the target price was adjusted from $280.00 to $300.00.

Zhitong FinanceMay 22 00:20

JP Morgan Maintains Overweight on United Therapeutics, Raises Price Target to $300

JP Morgan analyst Jessica Fye maintains United Therapeutics (NASDAQ:UTHR) with a Overweight and raises the price target from $280 to $300.

BenzingaMay 22 00:12

United Therapeutics Analyst Ratings

Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/21/2024 9.02% JP Morgan $280 → $300 Maintains Overweight 05/03/2024 -12.79% Goldman Sachs $218 → $240 M

BenzingaMay 22 00:11